Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001536368-25-000006

Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kunkel Lori Anne Director 2025-12-08 Option exercise +10,000 $7.90 $79,000 84,200 D
Derivatives
Kunkel Lori Anne Director 2025-12-08 Option exercise · Stock Option (right to buy) −10,000 15,600 D
Loading xslF345X05/form4-12092025_101258.xml…